"
Investigation of Methylation Profiles of TP53, Caspase 9, Caspase 8, Caspase 3 Genes Treated with DNA Methyl Transferase Inhibitor (DNMTi) Zebularine (ZEB) and Caffeic Acid Phenethyl Ester (CAPE) on MCF-7 and MDA-MB-231 Breast Cancer Cell Lines"
written by Onur Eroglu, Esin Guvenir Celik, Hacer Kaya, Merve Celen, Mustafa Karabicici, Elif Karacoban,
published by
Journal of Cancer Therapy,
Vol.10 No.1, 2019
has been cited by the following article(s):
[1]
|
Combined treatment with ruxolitinib and MK-2206 inhibits ERα activity by inhibiting MAPK signaling in BT474 breast cancer cells
Journal of Investigative Medicine,
2025
DOI:10.1177/10815589241298184
|
|
|
[2]
|
Synthesis, characterization, molecular docking studies of Mn(II)Prolinedithiocarbamate and its potential as anticancer agents
Molecular Diversity,
2024
DOI:10.1007/s11030-023-10627-5
|
|
|
[3]
|
Synthesis, characterization, molecular docking studies of Mn(II)Prolinedithiocarbamate and its potential as anticancer agents
Molecular Diversity,
2023
DOI:10.1007/s11030-023-10627-5
|
|
|
[4]
|
The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
Biomolecules,
2022
DOI:10.3390/biom12030367
|
|
|
[5]
|
The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
Biomolecules,
2022
DOI:10.3390/biom12030367
|
|
|
[6]
|
Methyl benzoate and cinnamate analogs as modulators of DNA methylation in hepatocellular carcinoma
Chemical Biology & Drug Design,
2022
DOI:10.1111/cbdd.14061
|
|
|